Peripheral artery disease (PAD) is a vascular disorder caused by occlusive atherosclerosis, which commonly impairs blood flow to the lower extremities. The prevalence of PAD is increasing globally ...

Primary care physicians play a vital role in identifying red flags for rare eosinophilic diseases like HES and EGPA, enabling ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Introduction Patients with difficult venous access experience undesirable effects during healthcare, such as delayed diagnosis and initiation of treatment, stress and pain related to the technique and ...

Background Previous studies in adults with asthma incorporating the control of sputum eosinophils into management strategies have shown significant reductions in exacerbations. A study was undertaken ...

What’s the prognostic value of basophilia and eosinophilia in primary myelofibrosis? These Minnesota-based researchers undertook the task of filling this knowledge gap.

Peripheral blood biomarkers Peripheral eosinophil counts As was found in the previous systematic review by Hines et al. (5), peripheral blood and peripheral blood products remain the most commonly ...

Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.

Complete resolution of eosinophilic infiltrate in EGE can also be achieved by exclusive feeding with an amino acid-based elemental diet.

Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

Increased eosinophil levels in COPD were associated with impaired abdominal aortic dynamics, highlighting a mechanistic link between eosinophilic inflammation and vascular dysfunction.

Atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects >230 million people worldwide ...